MACI

Vericel Corp (NASDAQ: VCEL), a nano-cap commercial-stage biopharmaceutical company that focuses on therapies which enable the body to repair and regenerate damaged tissues and organs, soared by more than 50 percent Tuesday morning. Vericel is currently developing MACI, a third-generation...

Shares of Vericel Corp (NASDAQ: VCEL), a developer of cellular therapies for use in the treatment of patients with diseases and conditions, were trading higher by nearly 4 percent on Tuesday morning. The move higher in Vericel's stock follows the company's announcement on Monday that it has...